Lansoprazole

Product overview

Lansoprazole pellets from Rraynex offer rapid acid control supported by enteric coatings that withstand harsh gastric environments. Manufacturing begins with pharmacopeial-grade active material, processed in contained equipment to protect the benzimidazole structure from oxidative stress. Pellets undergo layering that balances seal coats, drug deposition, and enteric polymers, preserving low ash content for clean downstream compression. Particle size distribution remains tight, enabling high-speed capsule filling without segregation or dusting. Each batch is scrutinized for assay, moisture, and dissolution in acidic and neutral media to guarantee robust proton pump inhibition. Commercial partners receive data packs featuring comparative dissolution against reference products, stability studies across climatic zones, and nitrosamine risk assessments. We offer packaging choices from moisture-barrier drums to nitrogen-flushed bags sized for clinical trials or hospital repacks. Technical support includes method transfers, compatibility studies with disintegrants, and recommendations for capsule shell selection when pursuing fast-disintegrating presentations. With our responsive quality management system and transparent change-control processes, lansoprazole supply from Rraynex remains consistent as brands expand into new geographies or line extensions.